Publication | Open Access
Neuroprotective and anticonvulsant effects of EGIS‐8332, a non‐competitive AMPA receptor antagonist, in a range of animal models
21
Citations
38
References
2007
Year
EGIS-8332 seems suitable for further development for the treatment of epilepsy, ischaemia and stroke based on its efficacy in a variety of experimental disease models, and on its low side effect potential.
| Year | Citations | |
|---|---|---|
Page 1
Page 1